Ascendis Pharma A/S
corporate_fare Company Profile
Ascendis Pharma A/S (NASDAQ:ASND) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for ASND at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Ascendis Pharma to Directly List Ordinary Shares on Nasdaq, Mandating ADS Exchange
- Achondroplasia Combo Therapy Shows Unprecedented Non-Linear Growth Benefits in Ascendis Pharma Trial
- FDA Grants Orphan Drug Exclusivity for YUVIWEL, Now Commercially Available in US
- Yuviwel Gains 7-Year U.S. Orphan Drug Exclusivity for Ascendis Pharma
- Ascendis Pharma Reports Positive Phase 2 Results for TransCon hGH in Turner Syndrome
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
€720.13M EUR
Net Income
-€228.03M EUR
Diluted EPS
-€3.76 EUR
Op. Cash Flow
€53.9M EUR
Gross Profit
€625.22M EUR
Operating Income
-€136.27M EUR
Cash & Equivalents
€616.04M EUR
Total Debt
€385.25M EUR
Debt / Equity
-2.37×
Net Margin
-31.7%
Shares Outstanding
61.98M sh
Source: 20-F · filed 2026-02-11 · accession 0001193125-26-046590
Insider Transactions
ASND files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.
show_chartPrice Chart
Loading chart...
feed ASND - Filings & News (Page 2)
ASND
Apr 08, 2026, 4:02 PM EDT
Price at Filing:
$233.95
Real-time Price:
$251.27
Change:
+$17.32 (+7%)
Market Cap:
$15.673B
ASND
Apr 08, 2026, 8:01 AM EDT
Achondroplasia Combo Therapy Shows Unprecedented Non-Linear Growth Benefits in Ascendis Pharma Trial
Price at Filing:
$226.96
Real-time Price:
$251.27
Change:
+$24.31 (+11%)
Market Cap:
$15.673B
ASND
Apr 07, 2026, 6:01 AM EDT
Price at Filing:
$228.00
Real-time Price:
$251.27
Change:
+$23.27 (+10%)
Market Cap:
$15.673B
ASND
Apr 06, 2026, 4:13 PM EDT
Price at Filing:
$228.00
Real-time Price:
$251.27
Change:
+$23.27 (+10%)
Market Cap:
$15.673B
ASND
Mar 17, 2026, 4:05 PM EDT
Price at Filing:
$228.06
Real-time Price:
$251.27
Change:
+$23.21 (+10%)
Market Cap:
$15.673B
ASND
Mar 17, 2026, 8:30 AM EDT
Price at Filing:
$231.12
Real-time Price:
$251.27
Change:
+$20.15 (+9%)
Market Cap:
$15.673B
ASND
Mar 16, 2026, 4:05 PM EDT
Price at Filing:
$231.03
Real-time Price:
$251.27
Change:
+$20.25 (+9%)
Market Cap:
$15.673B
ASND
Mar 16, 2026, 8:00 AM EDT
Price at Filing:
$229.01
Real-time Price:
$251.27
Change:
+$22.26 (+10%)
Market Cap:
$15.673B
ASND
Mar 05, 2026, 5:04 PM EST
Price at Filing:
$237.29
Real-time Price:
$251.27
Change:
+$13.98 (+6%)
Market Cap:
$15.673B
ASND
Mar 02, 2026, 6:05 AM EST
Price at Filing:
$241.00
Real-time Price:
$251.27
Change:
+$10.27 (+4%)
Market Cap:
$15.673B
ASND
Feb 27, 2026, 6:01 PM EST
Price at Filing:
$233.50
Real-time Price:
$251.27
Change:
+$17.77 (+8%)
Market Cap:
$15.673B
ASND
Feb 23, 2026, 4:05 PM EST
Price at Filing:
$234.95
Real-time Price:
$251.27
Change:
+$16.32 (+7%)
Market Cap:
$15.673B
ASND
Feb 11, 2026, 4:50 PM EST
Price at Filing:
$221.00
Real-time Price:
$251.27
Change:
+$30.27 (+14%)
Market Cap:
$15.673B
ASND
Feb 11, 2026, 4:15 PM EST
Price at Filing:
$216.23
Real-time Price:
$251.27
Change:
+$35.04 (+16%)
Market Cap:
$15.673B
ASND
Jan 12, 2026, 6:04 AM EST
Price at Filing:
$207.00
Real-time Price:
$251.27
Change:
+$44.27 (+21%)
Market Cap:
$15.673B
ASND
Jan 08, 2026, 6:26 PM EST
Price at Filing:
$208.75
Real-time Price:
$251.27
Change:
+$42.52 (+20%)
Market Cap:
$15.673B